In pancreatic ductal adenocarcinoma, loss of SMAD4 induces the upregulation and nuclear translocation of the glycolytic enzyme PGK1, resulting in high oxidative phosphorylation and metastatic potential.20 Here, SMAD4 is linked to pancreatic ductal adenocarcinoma.